4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000172
Director sold 5,000 shares at an average $76.27 ($381,367)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PARSHALL B LYNNE Director | 2026-04-15 | Sale 10b5-1 | −4,466 | $76.19 | $340,265 | 51,878 | D: show line 1 in the form |
| PARSHALL B LYNNE Director | 2026-04-15 | Sale 10b5-1 | −534 | $76.97 | $41,102 | 51,344 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $76.27 · $381,367 | |||||||
Loading xslF345X06/edgardoc.xml…